NASDAQ: SILO
Silo Pharma Inc Stock Ownership - Who owns Silo Pharma?

Insider buying vs selling

Have Silo Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric WeisblumChief Executive Officer2025-12-152,500$0.41
$1.03kBuy
Eric WeisblumChief Executive Officer2025-12-152,500$0.42
$1.05kBuy

1 of 1

SILO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SILO insiders and whales buy or sell their stock.

SILO Shareholders

What type of owners hold Silo Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eric Weisblum10.06%216,932$407.83kInsider
Daniel E. Ryweck0.23%5,000$9.40kInsider
Anson Funds Management LP0.00%104$195.52Institution
Advisorshares Investments LLC0.00%103$193.64Institution
Renaissance Technologies LLC0.00%23$43.24Institution
Citadel Advisors LLC0.00%16$30.08Institution
Vanguard Capital Management LLC0.00%12$22.56Institution
Geode Capital Management LLC0.00%11$20.68Institution
Two Sigma Investments LP0.00%11$20.68Institution
Virtu Financial LLC0.00%10$18.80Institution

1 of 2

SILO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SILO0.01%10.29%Net Buying
ALZN0.00%100.00%Net BuyingNet Selling
ADXN0.00%17.47%
XTLB0.00%11.97%
LTRN0.02%43.05%Net Buying

Silo Pharma Stock Ownership FAQ

Who owns Silo Pharma?

Silo Pharma (NASDAQ: SILO) is owned by 0.01% institutional shareholders, 10.29% Silo Pharma insiders, and 89.69% retail investors. Eric Weisblum is the largest individual Silo Pharma shareholder, owning 216,932.00 shares representing 10.06% of the company. Eric Weisblum's Silo Pharma shares are currently valued at $370.95k.

If you're new to stock investing, here's how to buy Silo Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.